When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Dova Pharmaceuticals (DOVA+17.4%) is up on average volume in apparent response to a bullish report from Wedbush centered on lead drug Doptelet (avatrombopag), approved in the U.S. in May 2018 for chronic liver disease (CLD) patients with thrombocytopenia (low blood platelets) who are undergoing a procedure and in June 2019 for patients with chronic immune thrombocytopenia (ITP).
More news on: Dova Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,